IL10 and COVID-19: Especially with respect to TNFα and IL-10, it was evident their concentrations were similar in both the COVID-19 patient groups with no cardiovascular co-morbidities and those with cardiovascular co-morbidities without statin use (Figure 2, Figure 3 and Figure 4).